Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of Elecsys® Troponin T Hs Gen 6 in Participants with Symptoms of Acute Coronary Syndrome
Active, not recruiting
- Conditions
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 5429
- Registration Number
- NCT06734117
- Locations
- 🇺🇸
El Centro Regional Medical Center, El Centro, California, United States
🇺🇸UCSD La Jolla ED, La Jolla, California, United States
🇺🇸University of Florida, Gainesville, Florida, United States
A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 10
- Registration Number
- NCT06733298
A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 854
- Registration Number
- NCT06723288
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 270
- Registration Number
- NCT06704672
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 850
- Registration Number
- NCT06680817
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
- First Posted Date
- 2024-11-06
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 500
- Registration Number
- NCT06675955
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
Recruiting
- Conditions
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 600
- Registration Number
- NCT06667414
- Locations
- 🇦🇺
WESTMEAD HOSPITAL; Deparment of Neurology, Westmead, New South Wales, Australia
🇩🇪Universitätsklinikum Ulm; Klinik für Neurologie, Ulm, Germany
🇬🇧National Hospital For Neurology and Neurosurgery, London, United Kingdom
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 50
- Registration Number
- NCT06624085
- Locations
- 🇺🇸
Saddleback Memorial Medical Center, Laguna Hills, California, United States
A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 150
- Registration Number
- NCT06624059
- Locations
- 🇨🇱
Centro de Estudios Clínicos SAGA, Santiago, Chile
🇨🇱OrlandiOncología, Santiago, Chile
🇨🇱Inst. Nacional Del Cancer; Servicio de Oncologia Medica, Santiago, Chile
A Study to Assess the Efficacy and Safety of RO7790121 for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 400
- Registration Number
- NCT06589986
- Locations
- 🇺🇸
Digestive Health Specialists, Dothan, Alabama, United States
🇺🇸Clinical Research of Osceola, LLC, Kissimmee, Florida, United States
🇺🇸Miami Beach Clinical Research Center, Miami Beach, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath